To determine the capacity of an infection-inhibiting, EC1-specific mAb to bind to sEC1-2 variants, ELISA plates were coated with serial twofold dilutions of WT or mutant sEC1-2 (starting concentration at 400 ng/well) overnight at 4 °C. After briefly washing with PBS, wells were blocked with 5% nonfat dry milk in PBS (1 h at RT) and incubated with anti-EC1 mAb-3305 (1 µg/mL, Donnelly Centre and Department of Molecular Genetics, University of Toronto) for 1 h at RT. After washing with PBS, the bound antibody was detected by incubation with an anti-human IgG HRP pAb (1:10,000 dilution, catalog No. AP112, Sigma-Aldrich) for 1 h at RT. ELISA signal was developed using 1-StepTM Ultra TMB-ELISA substrate solution (Thermo Scientific) and measured at an absorbance of 450 nm on a Cytation5 cell imaging multi-mode reader (Agilent BioTek Gen5 Microplate Reader and Imager software, V.3.2).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.